Buscar
Mostrando ítems 11-20 de 948
Th17 involvement in nonalcoholic fatty liver disease progression to non-Alcoholic steatohepatitis
(Baishideng Publishing Group, 2016-11)
The nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. NAFLD encompasses a wide histological spectrum ranging from benign simple steatosis to non-Alcoholic steatohepatitis ...
A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
(Associação Brasileira de Divulgação Científica, 2003-06-01)
In order to determine the effect of ursodeoxycholic acid on nonalcoholic fatty liver disease, 30 patients with body mass indices higher than 25, serum levels of alanine aminotransferase (ALT), aspartate aminotransferase ...
Role of exercise in the mechanisms ameliorating hepatic steatosis in non-alcoholic fatty liver disease
(Springer-Verlag Italia s.r.l., 2018)
Molecular pathways of nonalcoholic fatty liver disease development and progression
(Springer, 2019-01)
Nonalcoholic fatty liver disease (NAFLD) is a main hepatic manifestation of metabolic syndrome. It represents a wide spectrum of histopathological abnormalities ranging from simple steatosis to nonalcoholic steatohepatitis ...
Clinical Predictors of Different Grades of Nonalcoholic Fatty Liver Disease
(SPRINGERNEW YORK, 2012)
Nonalcoholic fatty liver disease (NAFLD) is one of the comorbidities related to obesity. Liver biopsy has been used as the "gold standard" for the diagnosis, grading, and prognosis of obese patients. The objective of the ...
Genetic basis of alcoholic and nonalcoholic fatty liver disease
(Springer, 2015)
The abnormal deposition of triglycerides in the liver is known as fatty liver. While the transformationof fatty liver may occur owing to a number of factors, it is often associated either with metabolic risk factors of the ...